Stable Psoriasis: Extension of Treatment Interval with Il23 Inhibitors Possible – Deutsches Ärzteblatt
Summary by Deutsches Ärzteblatt
1 Articles
1 Articles
Rome – A de-escalation strategy involving extended treatment intervals for IL23 inhibitors appears to be beneficial for maintaining efficacy and safety in psoriasis patients with stable disease control. This is suggested by a study presented at the XIV International Congress of Dermatology 2025 in Rome. The question of whether...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium